ARDS Prediction Score in Critically Ill Patients in China

Sponsor
Jianfeng Xie (Other)
Overall Status
Completed
CT.gov ID
NCT02174081
Collaborator
(none)
698
1
27
25.8

Study Details

Study Description

Brief Summary

ARDS is a severe disease, it's important to predict the incidence of ARDS.

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    From January 1 to January 31, 2012 and from January 1 to January 10, 2013 , all patients admit to the ICUs will be enrolled. The demographic characteristics, diagnosis, formerly medical history, Ventilator indications, Ventilator data, other respiratory treatments, weaning outcome and 28 day mortality will be recorded.

    Study Design

    Study Type:
    Observational
    Actual Enrollment :
    698 participants
    Observational Model:
    Cohort
    Official Title:
    ARDS Prediction Score in Critically Ill Patients in China
    Study Start Date :
    Mar 1, 2014
    Actual Primary Completion Date :
    Mar 1, 2016
    Actual Study Completion Date :
    Jun 1, 2016

    Outcome Measures

    Primary Outcome Measures

    1. incidence of ARDS [up to 24 months]

      evaluate the incidence of risk factors of ARDS

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years to 80 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:

    Critically ill patients who admitted into participating ICU

    Exclusion Criteria:

    Patients with chronic pulmonary disease such as chronic obstructive pulmonary disease (COPD), asthma, lung cancer, pulmonary fibrosis and tuberculosis Age less than 18 years old Pregnancy Died within 24 hours from ICU admission ARDS patients who diagnosed 24hours before ICU admission Referral from other hospital to participating ICU Lack of data of ARDS risk factors

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Zhongda Hospital Nanjing Jiangsu China 210009

    Sponsors and Collaborators

    • Jianfeng Xie

    Investigators

    • Principal Investigator: Jianfeng Xie, Dr, Southeast University

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Jianfeng Xie, Zhongda Hospital, Southeast University, China
    ClinicalTrials.gov Identifier:
    NCT02174081
    Other Study ID Numbers:
    • ARDS Prediction system
    First Posted:
    Jun 25, 2014
    Last Update Posted:
    Jun 28, 2016
    Last Verified:
    Jun 1, 2016
    Keywords provided by Jianfeng Xie, Zhongda Hospital, Southeast University, China
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Jun 28, 2016